AHA files briefs in defense of Louisiana's 340B contract pharmacy law

Apr 21, 2025 - 03:09 PM
340B-update-900x400

The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies. The briefs, filed in the U.S. Court of Appeals for the 5th Circuit, challenge claims by PhRMA, AbbVie and AstraZeneca that the federal law that created the 340B program preempts the state law.

The filings are the latest AHA has made in similar cases in multiple states. The AHA also filed friend-of-the-court briefs regarding the Louisiana cases in February 2024 and December 2023.

The Louisiana Hospital Association, Rural Hospital Coalition, 340B Health and the American Society of Health-System Pharmacists joined AHA in each of the latest filings.

Related News Articles

Headline
Eli Lilly moves to deny 340B pricing over data requirements; AHA urges federal action
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
Full 4th Circuit to rehear challenges to state contract pharmacy laws 
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
Wall Street Journal publishes AHA letter in response to anti-340B editorial
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
AHA urges Lilly to drop 340B claims-data policy, proposes neutral clearinghouse
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
AHA urges HRSA to act as Eli Lilly threatens 340B discounts over claims data submission policy
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
Washington Post publishes AHA letter in response to anti-340B editorial
The Washington Post yesterday published a letter to the editor from AHA President and CEO Rick Pollack responding to an April 18 editorial criticizing the 340B…